286 related articles for article (PubMed ID: 2224694)
1. Zidovudine (Retrovir) update.
Rachlis AR
CMAJ; 1990 Dec; 143(11):1177-85. PubMed ID: 2224694
[TBL] [Abstract][Full Text] [Related]
2. Toxic effects of zidovudine in asymptomatic human immunodeficiency virus-infected individuals with CD4+ cell counts of 0.50 x 10(9)/L or less. Detailed and updated results from protocol 019 of the AIDS Clinical Trials Group.
Koch MA; Volberding PA; Lagakos SW; Booth DK; Pettinelli C; Myers MW
Arch Intern Med; 1992 Nov; 152(11):2286-92. PubMed ID: 1359846
[TBL] [Abstract][Full Text] [Related]
3. [Recommendation of GESIDA (AIDS Study Group)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (I)].
Miró JM; Antela A; Arrizabalaga J; Clotet B; Gatell JM; Guerra L; Iribarren JA; Laguna F; Moreno S; Parras F; Rubio R; Santamaría JM; Viciana P
Enferm Infecc Microbiol Clin; 2000; 18(7):329-51. PubMed ID: 11109725
[TBL] [Abstract][Full Text] [Related]
4. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
5. [Anti-retroviral therapy of HIV-infection. With preliminary results of the Swiss postmarketing surveillance of zidovudine].
Jost J; Lüthy R
Schweiz Med Wochenschr; 1991 Apr; 121(16):555-65. PubMed ID: 1904164
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of treatment with AZT of patients with AIDS and symptomatic HIV infection.
Cox PH; Martin MA; Styer CM; Beall GN
Nurse Pract; 1990 May; 15(5):36, 39-44. PubMed ID: 2342666
[TBL] [Abstract][Full Text] [Related]
7. Zidovudine for the treatment of HIV infection.
Pepe R; Molavi A
Am Fam Physician; 1990 Aug; 42(2):437-43. PubMed ID: 2200250
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group.
Lenderking WR; Gelber RD; Cotton DJ; Cole BF; Goldhirsch A; Volberding PA; Testa MA
N Engl J Med; 1994 Mar; 330(11):738-43. PubMed ID: 7906386
[TBL] [Abstract][Full Text] [Related]
9. [Recommendations of GESIDA (Grupo de Estudio de SIDA)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (II)].
Miró JM; Antela A; Arrizabalaga J; Clotet B; Gatell JM; Guerra L; Antonio Iribarren J; Laguna F; Moreno S; Parras F; Rubio R; Santamaría JM; Viciana P;
Enferm Infecc Microbiol Clin; 2000 Oct; 18(8):396-412. PubMed ID: 11153204
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
11. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
12. [Early intervention in HIV infection].
Gotić M; Rolović Z; Elezović I; Marisavljević D; Berger D
Srp Arh Celok Lek; 1992 Nov; 120 Suppl 5():30-2. PubMed ID: 18170974
[TBL] [Abstract][Full Text] [Related]
13. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
14. [Antiretroviral therapy in Switzerland 1991].
Hirschel B; Vanhems P
Schweiz Med Wochenschr; 1991 Aug; 121(34):1187-93. PubMed ID: 1925447
[TBL] [Abstract][Full Text] [Related]
15. Management of HIV infection in adults.
Harrington PT
J Fla Med Assoc; 1991 Oct; 78(10):664-8. PubMed ID: 1753230
[TBL] [Abstract][Full Text] [Related]
16. Long-term zidovudine therapy in patients with AIDS and symptomatic and asymptomatic HIV infection.
Ebert S; Gockel K; Horowitz S; Weber P; Vogelman B; Graziano F
Wis Med J; 1991 Apr; 90(4):161-5. PubMed ID: 1675028
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex.
Schmitt FA; Bigley JW; McKinnis R; Logue PE; Evans RW; Drucker JL
N Engl J Med; 1988 Dec; 319(24):1573-8. PubMed ID: 3059187
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte-macrophage colony-stimulating factor and zidovudine in the treatment of neutropenia and human immunodeficiency virus infection.
Hewitt RG; Morse GD
Pharmacotherapy; 1992; 12(6):455-61. PubMed ID: 1492010
[TBL] [Abstract][Full Text] [Related]
19. Zidovudine. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
Wilde MI; Langtry HD
Drugs; 1993 Sep; 46(3):515-578. PubMed ID: 7693435
[TBL] [Abstract][Full Text] [Related]
20. Zidovudine (AZT) for treatment of patients infected with human immunodeficiency virus type 1. An evaluation of effectiveness in clinical practice.
Colson ER; Horwitz RI; Bia FJ; Viscoli CM
Arch Intern Med; 1991 Apr; 151(4):709-13. PubMed ID: 2012453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
